Seagen Inc.
SGENDelisted Dec 14, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001060736
Seagen Inc. was delisted on Dec 14, 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.3B in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Seagen Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 546 | 2 | 536 | −8 |
| Shares | 164.1M | 900 | 162.1M | −2.00M (−1.2%) |
| Value | $29.0B | $158.8K | $22.2B | −$6.85B (−23.6%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (66)
Institutions that held Seagen Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (74)
Institutions that held Seagen Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
Not filed for Q3 2022 yet (2)
Institutions that held Seagen Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 864 | $152.8K |
| Private Capital Group, LLC | 36 | $6.00K |